CDC finds few breakthrough infections To view this email as a web page,
click here With plant-based manufacturing platform, Medicago takes COVID-19 vaccine production into the greenhouse Moderna aims to launch a single-dose COVID-19 vaccine next year in India: report UPDATED Coronavirus tracker: CDC study finds few breakthrough infections, even fewer hospitalizations Pitt's inhalable 'nanobody' fights off COVID-19 in hamsters at ultralow doses COVID-19 tracker: EU investigates death in Belgium after J&J shot; Biden orders probe into Covid origins Food safety tester Clear Labs raises $60M to chase COVID-19 variants VillageMD grows its footprint in Houston as COVID-19 shines light on need for accessible primary care Featured Story | By Fraiser Kansteiner During the span of the COVID-19 pandemic, mRNA vaccines have gone from being promising technology in the lab to blockbuster products in the real world. In the pandemic's second year, Medicago is hoping to repeat that magic with plant-based prophylactics. read more |
| |
|---|
|
Top Stories By Kevin Dunleavy Moderna plans to launch a single-dose version of its COVID-19 vaccine in India next year and is in discussion with companies in the country to supply it, India's PTI news agency reports. Plus, Pfizer will supply 50 million vaccine doses to India from July to October of this year, the report says. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Angus Liu Existing COVID-19 monoclonal antibodies require high doses to be effective against the disease. Now, scientists at the University of Pittsburg showed that very low doses of a tiny antibody known as a “nanobody,” administered directly through the nose or by inhalation, could prevent and treat severe COVID in hamsters. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner The European Union's drug regulator is investigating the death of a woman in Belgium who received J&J's single-dose vaccine and developed a blood clot. President Joe Biden ordered U.S. intelligence to develop a report on COVID-19's origins in 90 days. And more headlines. read more By Conor Hale Clear Labs is looking to put down new roots in the fight against COVID-19 by pivoting its genomic testing tech previously aimed at catching salmonella and listeria before they reach the dinner table. read more By Jacqueline Renfrow Among the many challenges brought by COVID-19 the pandemic also has shone a spotlight on the importance of primary care providers. Clive Fields, M.D., VillageMD co-founder, details the company's expansion in the Houston market and efforts to increase broad-based, universally accessible primary care. read more |
|
